botulinum toxin neuromodulator

BIOLOGICAL2 trials

Sponsors

Galderma R&D

Conditions

Glabellar Frown Lines (GL)Glabellar LinesLateral Canthal LinesLateral Canthal Lines (LCL)

Phase 3

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

CompletedNCT04225260

Galderma R&DGlabellar Lines, Lateral Canthal Lines

Start: 2020-01-27End: 2021-05-21Updated: 2023-06-18

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

CompletedNCT04247074

Galderma R&DGlabellar Frown Lines (GL), Lateral Canthal Lines (LCL)

Start: 2020-02-10End: 2021-02-26Updated: 2023-09-06